HR+/HER2- Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review.

Curr Oncol · 2023 · PMC10297170 · PMID 37366894

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

In such cases, abemaciclib would be preferred as it demonstrated a strong trend of prolonged OS at an interim MONARCH-3 analysis.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.